Fig. 3From: Neurological management and work-up of neurotoxicity associated with CAR T cell therapyTypical ICANS symptoms independent of ICANS grading. Symptoms occurring in the cases described above are printed in bold and blue. Severity of symptoms increases from left to rightBack to article page